Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL3564413

N.N#Cc1cccc(C[C@H](N)C(=O)O)c1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.58
SLC7A5 Q01650 8/20 0.57
PTGS1 P23219 2/20 0.57
ALPI P09923 1/20 0.57
PKM P14618 1/20 0.57
XIAP P98170 1/20 0.57
DPP4 P27487 2/20 0.55
DPP7 Q9UHL4 2/20 0.55
FAP Q12884 1/20 0.55
DPP8 Q6V1X1 1/20 0.55
DPP9 Q86TI2 1/20 0.55
GRIA2 P42262 1/20 0.55
NOS3 P29474 2/20 0.54
NOS1 P29475 2/20 0.54
NOS2 P35228 2/20 0.54
GRM4 Q14833 1/20 0.50
KDM4E B2RXH2 1/20 0.50
USP2 O75604 1/20 0.50
EGFR P00533 1/20 0.50
LCK P06239 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL3564410 1.00 FOLH1 (0.58) FOLH1SLC7A5PTGS1ALPIPKM
Ammonia Solution, Strong SCHEMBL3564412 1.00 FOLH1 (0.58) FOLH1SLC7A5PTGS1ALPIPKM
SCHEMBL43812 0.98 FOLH1 (0.59) FOLH1SLC7A5PTGS1ALPIPKM
SCHEMBL29557415 0.98 FOLH1 (0.59) FOLH1SLC7A5PTGS1ALPIPKM
SCHEMBL29397955 0.98 FOLH1 (0.59) FOLH1SLC7A5PTGS1ALPIPKM
SCHEMBL43811 0.98 FOLH1 (0.59) FOLH1SLC7A5PTGS1ALPIPKM
SCHEMBL838038 0.98 FOLH1 (0.59) FOLH1SLC7A5PTGS1ALPIPKM
Hydrochloric Acid SCHEMBL7591933 0.97 FOLH1 (0.58) FOLH1SLC7A5PTGS1ALPIPKM
Hydrochloric Acid SCHEMBL7042048 0.97 FOLH1 (0.58) FOLH1SLC7A5PTGS1ALPIPKM
Hydrochloric Acid SCHEMBL27695050 0.97 FOLH1 (0.58) FOLH1SLC7A5PTGS1ALPIPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7659396-B2 Method for the production of phenylalanine derivatives WILEX AG (DE) 2010-02-09 US claimed
US-20090005562-A1 Method for the Production of Phenylalanine Derivatives WILEX AG (DE) 2009-01-01 US claimed
US-7659396-B2 Method for the production of phenylalanine derivatives WILEX AG (DE) 2010-02-09 US disclosed
US-20090005562-A1 Method for the Production of Phenylalanine Derivatives WILEX AG (DE) 2009-01-01 US disclosed
US-7247724-B2 Method for the production of phenylalanine derivatives WILEX AG (DE) 2007-07-24 US disclosed
US-20050245757-A1 Method for the production of phenylalanine derivatives WILEX AG (DE) 2005-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005562-A1 Method for the Production of Phenylalanine Derivatives PAH, NPEPPS, DNPEP FOLH1 195/4885SLC7A5 260/4885PTGS1 2513/4885
US-20050245757-A1 Method for the production of phenylalanine derivatives PAH, NPEPPS, DNPEP FOLH1 195/4885SLC7A5 260/4885PTGS1 2513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.